- Home
- ONC vs FMX Comparison
ONC vs FMX Comparison
Compare ONC & FMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | FMX |
|---|---|---|
| Founded | 2010 | 1890 |
| Country | Switzerland | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 35.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ONC | FMX |
|---|---|---|
| Price | $312.21 | $103.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $369.50 | $101.63 |
| AVG Volume (30 Days) | 256.0K | ★ 492.0K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 5.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.58 | 0.26 |
| Revenue | $4,972,687,000.00 | ★ $45,227,355,169.00 |
| Revenue This Year | $895.40 | $10.20 |
| Revenue Next Year | $22.04 | $7.96 |
| P/E Ratio | $504.28 | ★ $36.79 |
| Revenue Growth | ★ 50.43 | 9.77 |
| 52 Week Low | $172.67 | $81.08 |
| 52 Week High | $385.22 | $108.74 |
Technical Indicators
Market Signals| Indicator | ONC | FMX |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 60.54 |
| Support Level | $306.61 | $98.64 |
| Resistance Level | $314.46 | $103.34 |
| Average True Range (ATR) | 7.03 | 2.38 |
| MACD | -0.42 | -0.12 |
| Stochastic Oscillator | 40.38 | 69.80 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.